Report overview
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing & Diagnostics. This report contains market size and forecasts of Respiratory Disease Testing & Diagnostics in global, including the following market information:
Global Respiratory Disease Testing & Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Respiratory Disease Testing & Diagnostics market was valued at US$ 4661.5 million in 2022 and is projected to reach US$ 5278.1 million by 2029, at a CAGR of 1.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing popularity of portable devices such as advanced respirometers and non-invasive ventilators are the leading causes of North America.
We surveyed the Respiratory Disease Testing & Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Disease Testing & Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Respiratory Disease Testing & Diagnostics Market Segment Percentages, by Type, 2022 (%)
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Global Respiratory Disease Testing & Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Respiratory Disease Testing & Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Physician Clinics
Clinical Laboratories
Other
Global Respiratory Disease Testing & Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Respiratory Disease Testing & Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Disease Testing & Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Respiratory Disease Testing & Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Disease Testing & Diagnostics, market overview.
Chapter 2: Global Respiratory Disease Testing & Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Respiratory Disease Testing & Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Disease Testing & Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
